Kelly Keefe

464 total citations
19 papers, 341 citations indexed

About

Kelly Keefe is a scholar working on Ophthalmology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kelly Keefe has authored 19 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Ophthalmology, 8 papers in Epidemiology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kelly Keefe's work include Ocular Diseases and Behçet’s Syndrome (9 papers), Retinal Diseases and Treatments (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). Kelly Keefe is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (9 papers), Retinal Diseases and Treatments (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). Kelly Keefe collaborates with scholars based in United States, Belgium and France. Kelly Keefe's co-authors include Ian W. McLean, Miguel N. Burnier, William R. Freeman, Clayton A. Wiley, Kelly Soules, Krzysztof Appelt, İbrahim Taşkintuna, Lingyun Cheng, Michael F. Gardner and Alay Banker and has published in prestigious journals such as Ophthalmology, Journal of Pharmacology and Experimental Therapeutics and Ecological Economics.

In The Last Decade

Kelly Keefe

18 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Keefe United States 11 238 86 85 82 26 19 341
Zhang Jing China 10 63 0.3× 39 0.5× 71 0.8× 58 0.7× 15 0.6× 31 294
Eva-Marie Chong United States 8 132 0.6× 43 0.5× 42 0.5× 142 1.7× 12 0.5× 8 296
P. Bauer Germany 8 129 0.5× 10 0.1× 56 0.7× 153 1.9× 24 0.9× 12 299
Sung-Ho Choi South Korea 10 185 0.8× 128 1.5× 69 0.8× 225 2.7× 12 0.5× 22 392
Xunda Ji China 14 265 1.1× 64 0.7× 99 1.2× 274 3.3× 51 2.0× 32 545
Armin R. Afshar United States 11 301 1.3× 30 0.3× 93 1.1× 138 1.7× 18 0.7× 45 400
Mark S. Jenkins United States 8 71 0.3× 23 0.3× 47 0.6× 164 2.0× 108 4.2× 11 385
Yu-Feng Yao China 11 155 0.7× 31 0.4× 23 0.3× 320 3.9× 9 0.3× 36 434
O. Akhayat Morocco 9 76 0.3× 17 0.2× 87 1.0× 46 0.6× 4 0.2× 10 500
C Gailloud Switzerland 11 252 1.1× 24 0.3× 47 0.6× 92 1.1× 2 0.1× 48 299

Countries citing papers authored by Kelly Keefe

Since Specialization
Citations

This map shows the geographic impact of Kelly Keefe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Keefe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Keefe more than expected).

Fields of papers citing papers by Kelly Keefe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Keefe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Keefe. The network helps show where Kelly Keefe may publish in the future.

Co-authorship network of co-authors of Kelly Keefe

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Keefe. A scholar is included among the top collaborators of Kelly Keefe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Keefe. Kelly Keefe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Anding, Allyson L., Kaitlyn Baranowski, Michael R. Dufault, et al.. (2023). Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice. Journal of Pharmacology and Experimental Therapeutics. 387(2). 188–203. 6 indexed citations
2.
Proeschold‐Bell, Rae Jean, Jia Yao, David E. Eagle, et al.. (2021). Changes in Sabbath-Keeping and Mental Health Over Time: Evaluation Findings From the Sabbath Living Study. Journal of Psychology and Theology. 50(2). 123–138. 5 indexed citations
3.
Richardson, Leslie, et al.. (2014). Assessing the value of the Central Everglades Planning Project (CEPP) in Everglades restoration: An ecosystem service approach. Ecological Economics. 107. 366–377. 17 indexed citations
4.
Prall, Friedrich, et al.. (2010). RETINAL PIGMENT EPITHELIUM TEAR IN VOGT–KOYANAGI–HARADA DISEASE. Retinal Cases & Brief Reports. 5(4). 284–286. 2 indexed citations
5.
Keefe, M.A., et al.. (2005). Use of Image-Guided Systems in the Reconstruction of the Periorbital Region. Archives of Facial Plastic Surgery. 7(4). 266–271.
6.
Keefe, M.A., et al.. (2002). Orbital Paraffinoma as a Complication of Endoscopic Sinus Surgery. Otolaryngology. 127(6). 575–577. 10 indexed citations
7.
Cheng, Lingyun, Kelly Keefe, Clayton A. Wiley, et al.. (2001). Evaluation of Intraocular Pharmacokinetics and Toxicity of Prinomastat (AG3340) in the Rabbit. Journal of Ocular Pharmacology and Therapeutics. 17(3). 295–304. 17 indexed citations
8.
Özerdem, Uğur, et al.. (2000). The Effect of Prinomastat (AG3340), a Synthetic Inhibitor of Matrix Metalloproteinases, on Posttraumatic Proliferative Vitreoretinopathy. Ophthalmic Research. 33(1). 20–23. 22 indexed citations
9.
Özerdem, Uğur, Lingyun Cheng, Sunan Chaidhawangul, et al.. (2000). The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy. Current Eye Research. 20(6). 447–453. 22 indexed citations
10.
Cheng, Lingyun, Karl Y. Hostetler, Sunan Chaidhawangul, et al.. (2000). Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.. PubMed. 41(6). 1523–32. 39 indexed citations
11.
Cheng, Lingyun, Karl Y. Hostetler, Michael F. Gardner, et al.. (1999). Intravitreal Toxicology and Therapeutic Efficacy of the Carboxymethyl Ester of the l- O -Octadecyl- sn -Glycerol-3-Phosphonoformate (ODG-PFA-O-Me), a Novel Lipid Antiviral Prodrug for Intraocular Drug Delivery. Journal of Ocular Pharmacology and Therapeutics. 15(4). 363–377. 1 indexed citations
12.
Cheng, Lingyun, Karl Y. Hostetler, Michael F. Gardner, et al.. (1999). Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.. PubMed. 40(7). 1487–95. 21 indexed citations
13.
Cheng, Lingyun, et al.. (1998). Cytomegalovirus Iritis. Ophthalmic surgery, lasers & imaging retina. 29(11). 930–932. 10 indexed citations
14.
Banker, Alay, et al.. (1998). Effects of topical and subconjunctival cidofovir (HPMPC) in an animal model. Current Eye Research. 17(6). 560–566. 8 indexed citations
15.
Banker, Alay, et al.. (1998). Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes.. PubMed. 39(7). 1233–42. 10 indexed citations
16.
Taşkintuna, İbrahim, Alay Banker, N A Rao, et al.. (1997). An Animal Model for Cidofovir (HPMPC) Toxicity: Intraocular Pressure and Histopathologic Effects. Experimental Eye Research. 64(5). 795–806. 25 indexed citations
17.
McLean, Ian W., Kelly Keefe, & Miguel N. Burnier. (1997). Uveal Melanoma. Ophthalmology. 104(5). 777–780. 84 indexed citations
18.
Kuppermann, Baruch D., Jose I. Quiceno, Clayton A. Wiley, et al.. (1994). Clinical and Histopathologic Study of Varicella Zoster Virus Retinitis in Patients With the Acquired Immunodeficiency Syndrome. American Journal of Ophthalmology. 118(5). 589–600. 36 indexed citations
19.
Keefe, Kelly, et al.. (1992). Atypical Healing of Cytomegalovirus Retinitis. Ophthalmology. 99(9). 1377–1384. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026